This page is part of the FHIR Specification (v5.0.0: R5 - STU). This is the current published version in it's permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Example DetectedIssue/ddi (Turtle)
Raw Turtle (+ also see Turtle/RDF Format Specification)
Drug-drug interaction between prescription and medication statement
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
[a fhir:DetectedIssue ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "ddi"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p><b>Severity: High</b> - Risk of internal bleeding</p>\n <p>Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding.</p>\n <ul>\n <li><a href=\"MedicationStatement/tylenol\">500 mg Acetaminophen tablet 1/day, PRN since 2010</a></li>\n <li><a href=\"MedicationRequest/warfarin\">Warfarin 1 MG TAB prescribed Jan. 5, 2014</a></li>\n </ul>\n <p>Mitigation: Jan 5, 2014 by Dr. Adam Careful: </p>\n <p>Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring</p>\n </div>"
] ; #
fhir:status [ fhir:v "final"] ; #
fhir:category ( [
fhir:coding ( [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-ActCode"^^xsd:anyURI ] ;
fhir:code [ fhir:v "DRG" ] ;
fhir:display [ fhir:v "Drug Interaction Alert" ]
] )
] ) ; #
fhir:code [
fhir:coding ( [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-ActCode"^^xsd:anyURI ] ;
fhir:code [ fhir:v "DRG" ] ;
fhir:display [ fhir:v "Drug Interaction Alert" ]
] )
] ; #
fhir:severity [ fhir:v "high"] ; #
fhir:subject [
fhir:reference [ fhir:v "Device/example" ]
] ; #
fhir:identified [ fhir:v "2014-01-05"^^xsd:date] ; #
fhir:implicated ( [
fhir:reference [ fhir:v "MedicationStatement/example001" ] ;
fhir:display [ fhir:v "500 mg Acetaminophen tablet 1/day, PRN since 2010" ]
] [
fhir:reference [ fhir:v "MedicationRequest/medrx0331" ] ;
fhir:display [ fhir:v "Warfarin 1 MG TAB prescribed Jan. 15, 2015" ]
] ) ; #
fhir:detail [ fhir:v "Risk of internal bleeding. Those who take acetaminophen along with the widely used blood-thinning drug warfarin may face the risk of serious internal bleeding. People on warfarin who take acetaminophen for at least seven days in a row should be closely watched for bleeding."] ; #
fhir:mitigation ( [
fhir:action [
fhir:coding ( [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v3-ActCode"^^xsd:anyURI ] ;
fhir:code [ fhir:v "13" ] ;
fhir:display [ fhir:v "Stopped Concurrent Therapy" ]
] ) ;
fhir:text [ fhir:v "Asked patient to discontinue regular use of Tylenol and to consult with clinician if they need to resume to allow appropriate INR monitoring" ]
] ;
fhir:date [ fhir:v "2014-01-05"^^xsd:date ] ;
fhir:author [
fhir:reference [ fhir:v "Practitioner/example" ] ;
fhir:display [ fhir:v "Dr. Adam Careful" ]
]
] )] . #
# -------------------------------------------------------------------------------------
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.